Johnson & Johnson misses revenue estimates as blockbuster drugs disappoint

Johnson & Johnson narrowly missed quarterly revenue estimates on Wednesday as sales of its blockbuster psoriasis medicine Stelara and cancer drug Imbruvica fell short of expectations.
via FOX BUSINESS NEWS https://ift.tt/38yt7SW
No comments:
Post a Comment